Indications for use

CirrhoCare® is intended for out-of-hospital specialist hepatology management follow-up of adult cirrhosis patients ages 22 and older. CirrhoCare® is intended to identify new preventable decompensation events [such as dehydration (acute kidney injury), new accumulation of ascites, infection or hepatic encephalopathy] for a healthcare provider to take immediate clinical action, allowing the opportunity for early outpatient-based interventions.

CirrhoCare® is intended for active remote management for up to 3 months. A more standard medium-term outpatient clinical follow-up pathway can be resumed in patients who remain stable on CirrhoCare® for up to 3 months. For those who remain unstable or with signs of frequent new complications, management can be continued beyond 3 months.